Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robots vs. hands: a precision showdown for hip fracture surgery

NCT ID NCT07738458

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial compares robot-assisted reduction with traditional manual methods for treating a common type of hip fracture in adults aged 18 to 80. The goal is to see if the robotic system can achieve more precise bone alignment, reduce radiation exposure, and improve long-term hip function and quality of life. Participants are randomly assigned to receive either robot-assisted or manual reduction, followed by standard internal fixation surgery, and are monitored for six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Robot-assisted closed reduction and internal fixation procedure
What this could lead to
If successful, this could establish a more precise, safer standard for treating hip fractures, potentially improving recovery and reducing complications.
What could go wrong
The trial is small (60 participants) and early, so results may not apply broadly. Robotic systems can fail or have technical issues, and the procedure may not outperform skilled manual reduction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 to 80 years, inclusive. * Male or female participants. * Acute, closed intertrochanteric femoral fracture. * AO/OTA classification 31-A intertrochanteric femoral fracture. * Fracture requiring closed reduction and proximal femoral intramedullary nailing. * Injury-to-surgery interval no more than 14 days. * Participant or legally authorized representative is fully informed about the study. * Written informed consent voluntarily provided by the participant or legally authorized representative. Exclusion Criteria: * Open fracture. * Pathological fracture. * Old fracture with an injury-to-surgery interval greater than 14 days. * Multiple fractures. * Previous surgery involving the affected hip joint. * Deformity of the affected hip joint. * Severe osteoarthritis of the affected hip joint. * Significant neuromuscular disease affecting lower limb function. * Significant neuromuscular disease affecting postoperative rehabilitation. * Severe systemic comorbidity that makes the participant unable to tolerate anesthesia or surgery. * Severe organ dysfunction that makes the participant unable to tolerate anesthesia or surgery. * Pregnancy. * Lactation. * Cognitive impairment that prevents compliance with postoperative follow-up or rehabilitation protocols. * Active psychiatric illness that prevents compliance with postoperative follow-up or rehabilitation protocols. * Other condition that prevents compliance with postoperative follow-up or rehabilitation protocols. * Current participation in another clinical trial that may interfere with evaluation of this study's outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intertrochanteric fractures are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Beijing Jishuitan Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100035, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.